Therachon is Granted Orphan Drug Designation by US FDA for Apraglutide for the Treatment of Short Bo

Second Orphan Drug Designation for apraglutide, a next-generation, synthetic GLP-2 analog with a potentially best-in-class profile BASEL, Switzerland, Jan. ... Lees verder

Bron:

ANP Pers support